These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 12678807)

  • 1. Perspective in antimalarial chemotherapy.
    Kumar A; Katiyar SB; Agarwal A; Chauhan PM
    Curr Med Chem; 2003 Jul; 10(13):1137-50. PubMed ID: 12678807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From hybrid compounds to targeted drug delivery in antimalarial therapy.
    Oliveira R; Miranda D; Magalhães J; Capela R; Perry MJ; O'Neill PM; Moreira R; Lopes F
    Bioorg Med Chem; 2015 Aug; 23(16):5120-30. PubMed ID: 25913864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisquinoline antimalarials: their role in malaria chemotherapy.
    Raynes K
    Int J Parasitol; 1999 Mar; 29(3):367-79. PubMed ID: 10333319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Falcipain inhibitors as potential therapeutics for resistant strains of malaria: a patent review.
    Mane UR; Gupta RC; Nadkarni SS; Giridhar RR; Naik PP; Yadav MR
    Expert Opin Ther Pat; 2013 Feb; 23(2):165-87. PubMed ID: 23228154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to antimalarial compounds: methods and applications.
    Witkowski B; Berry A; Benoit-Vical F
    Drug Resist Updat; 2009; 12(1-2):42-50. PubMed ID: 19285915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Structural Chemistry Perspective on the Antimalarial Properties of Thiosemicarbazone Metal Complexes.
    Summers KL
    Mini Rev Med Chem; 2019; 19(7):569-590. PubMed ID: 30324878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antimalarial activity of indole alkaloids and hybrids.
    Li JY; Sun XF; Li JJ; Yu F; Zhang Y; Huang XJ; Jiang FX
    Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000131. PubMed ID: 32785974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Present trends and future strategy in chemotherapy of malaria.
    Chauhan PM; Srivastava SK
    Curr Med Chem; 2001 Nov; 8(13):1535-42. PubMed ID: 11562283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review on in-vitro anti-malarial activity of natural β-carboline alkaloids.
    Ashok P; Ganguly S; Murugesan S
    Mini Rev Med Chem; 2013 Oct; 13(12):1778-91. PubMed ID: 24059727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manzamine alkaloids: isolation, cytotoxicity, antimalarial activity and SAR studies.
    Ashok P; Ganguly S; Murugesan S
    Drug Discov Today; 2014 Nov; 19(11):1781-1791. PubMed ID: 24953707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo.
    Soares RR; da Silva JM; Carlos BC; da Fonseca CC; de Souza LS; Lopes FV; de Paula Dias RM; Moreira PO; Abramo C; Viana GH; de Pila Varotti F; da Silva AD; Scopel KK
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2308-13. PubMed ID: 25920564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Development Process for Discovery and Clinical Advancement of Modern Antimalarials.
    Ashton TD; Devine SM; Möhrle JJ; Laleu B; Burrows JN; Charman SA; Creek DJ; Sleebs BE
    J Med Chem; 2019 Dec; 62(23):10526-10562. PubMed ID: 31385706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in antimalarial drug development.
    Vangapandu S; Jain M; Kaur K; Patil P; Patel SR; Jain R
    Med Res Rev; 2007 Jan; 27(1):65-107. PubMed ID: 16700012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive review on various strategies for antimalarial drug discovery.
    Mishra M; Mishra VK; Kashaw V; Iyer AK; Kashaw SK
    Eur J Med Chem; 2017 Jan; 125():1300-1320. PubMed ID: 27886547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum.
    Das U; Singh RS; Alcorn J; Hickman MR; Sciotti RJ; Leed SE; Lee PJ; Roncal N; Dimmock JR
    Bioorg Med Chem; 2013 Dec; 21(23):7250-6. PubMed ID: 24139941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinoline-based antimalarial hybrid compounds.
    Vandekerckhove S; D'hooghe M
    Bioorg Med Chem; 2015 Aug; 23(16):5098-119. PubMed ID: 25593097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malaria chemotherapy: recent advances in drug development.
    Gemma S; Travagli V; Savini L; Novellino E; Campiani G; Butini S
    Recent Pat Antiinfect Drug Discov; 2010 Nov; 5(3):195-225. PubMed ID: 20738242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel molecular targets for antimalarial chemotherapy.
    Jana S; Paliwal J
    Int J Antimicrob Agents; 2007 Jul; 30(1):4-10. PubMed ID: 17339102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel antimalarial chloroquine- and primaquine-quinoxaline 1,4-di-N-oxide hybrids: Design, synthesis, Plasmodium life cycle stage profile, and preliminary toxicity studies.
    Bonilla-Ramirez L; Rios A; Quiliano M; Ramirez-Calderon G; Beltrán-Hortelano I; Franetich JF; Corcuera L; Bordessoulles M; Vettorazzi A; López de Cerain A; Aldana I; Mazier D; Pabón A; Galiano S
    Eur J Med Chem; 2018 Oct; 158():68-81. PubMed ID: 30199706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of the first oral bioprecursors of bis-alkylguanidine antimalarial drugs.
    Degardin M; Wein S; Duckert JF; Maynadier M; Guy A; Durand T; Escale R; Vial H; Vo-Hoang Y
    ChemMedChem; 2014 Feb; 9(2):300-4. PubMed ID: 24403182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.